Novartis Looks To Maintain A Lead In Radiopharmaceuticals With Mariana Takeout

 
• By Joseph Haas
  
Radioligand therapeutic
Novartis buys Mariana Oncology to increase its holdings in radioligand therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business